Yes, you can have a hip replacement with osteopenia. Osteopenia is not a disqualifier for surgery. It does change how surgeons plan the procedure, which implant they choose, and how they manage your bone health before and after. Most people with osteopenia proceed to a standard total hip replacement with good outcomes when the diagnosis is identified and addressed. The decisions that matter are implant fixation, bone-quality assessment, and a perioperative plan for your skeleton — not whether the operation is allowed.

Osteopenia sits between normal bone density and osteoporosis on a DXA scan. That middle zone is where surgical judgment gets interesting. A hip with mildly low bone mineral density tolerates an uncemented press-fit cup and stem in most cases. A hip with fragile bone, thin cortices, or a density value drifting toward osteoporosis may need cement, a different stem geometry, or a preoperative bone-health workup. The rest of this explainer walks through the mechanobiology, the numbers, the edge cases, and the practical steps that separate a routine osteopenic hip from a complicated one.

How Low Bone Density Alters Implant Fixation

A total hip replacement succeeds or fails on the interface between implant and bone. Uncemented implants rely on press-fit: the surgeon impacts a slightly oversized metal component into prepared bone, and the resulting compressive stress plus bony ingrowth locks it in place over 6 to 12 weeks. That mechanism depends on bone that can tolerate impact strain and generate a biological response. Osteopenic bone has thinner trabeculae, fewer load-bearing struts, and lower peak compressive strength. It still ingrows, but the margin for error narrows.

Cemented fixation works differently. Polymethyl methacrylate fills the space between bone and implant and cures into a grout-like layer that distributes load across a broader surface. Cement does not need the bone to generate ingrowth. It needs the bone to hold the cement mantle without fracturing during impaction and to keep that mantle contained over years. In softer bone, cement can actually outperform press-fit because it compensates for weak trabecular architecture. This is why cement remains common in older patients and in revision settings.

The clinical consequence is not "osteopenia means cemented." It means the surgeon reads your DXA value, your femoral morphology, your cortical thickness on plain films, and your age, then picks the fixation strategy that matches the bone in front of them. The same disease produces different decisions in a 58-year-old with a T-score of −1.2 and an 80-year-old with a T-score of −2.4 and thin cortices.

The Numbers: T-Scores, Thresholds, and What They Predict

Bone density is reported as a T-score: standard deviations from the mean of a young healthy reference population. The World Health Organization defines normal as −1.0 or above, osteopenia (low bone mass) as between −1.0 and −2.5, and osteoporosis as −2.5 or below. These are diagnostic bands, not surgical cutoffs. No major orthopedic society publishes a T-score below which hip replacement is contraindicated.

What the bands predict is fracture risk and implant behavior. Each standard deviation drop in hip BMD roughly doubles hip fracture risk in epidemiologic data. A T-score of −2.0 carries meaningfully more risk than −1.2, even though both are labeled osteopenia. That is why surgeons treat the number as a continuum, not a label.

Other numbers that enter the decision:

Periprosthetic fracture rates after uncemented hip replacement rise in patients with low BMD, with registry and cohort data consistently showing higher risk in osteoporotic ranges and a graded increase through osteopenia. Cortical thickness on the femoral diaphysis below roughly 4 to 5 mm flags a femur that may not tolerate a press-fit stem without hoop-stress fracture. A DXA T-score of −2.5 or lower at the hip or spine typically triggers a preoperative osteoporosis evaluation and consideration of bone-building or antiresorptive therapy before or around surgery. Serum vitamin D below 20 ng/mL is common in candidates for joint replacement and impairs bone healing; correction is inexpensive and standard. A FRAX 10-year major osteoporotic fracture probability of 20 percent or higher, or hip fracture probability of 3 percent or higher, is a common treatment threshold — and it can be met by someone whose T-score still reads osteopenia.

The reconciliation point matters: WHO diagnostic bands and FRAX treatment thresholds answer different questions. The DXA band tells you what your density is. FRAX tells you what your fracture risk is. A person with osteopenia by DXA can cross the FRAX treatment threshold because of age, prior fracture, steroid use, or smoking. Surgeons care about both.

Comparison: Fixation and Implant Options in Osteopenic Bone

Option Mechanism Best suited to Main trade-off
Uncemented press-fit cup and stem Compressive press-fit plus bony ingrowth T-score above roughly −1.5, adequate cortical thickness, younger patients Higher intraoperative and early periprosthetic fracture risk in weak bone
Fully cemented stem with uncemented or cemented cup Cement mantle distributes load, no ingrowth required Older patients, thin cortices, T-score drifting toward −2.5 Longer operative time, cement-implantation reactions, harder future revision
Hybrid (cemented stem, uncemented cup) Combines cement load-sharing in the femur with press-fit acetabular fixation Mixed bone quality, femoral weakness with decent acetabular bone Two fixation philosophies to manage
Cementless stem with diaphyseal-engaging or wedge geometry Loads stronger cortical bone distal to the metaphysis Proximal femoral osteopenia with intact diaphysis Requires adequate distal bone stock
Revision-style or long stem Bypasses weak proximal bone entirely Severe proximal bone loss, periprosthetic fracture setting More invasive, longer recovery
Bone-health optimization before elective surgery Corrects vitamin D, calcium intake, treats osteoporosis Anyone with T-score near −2.5, FRAX above threshold, or fragility fracture history Delays surgery by weeks to months

Edge Cases That Change the Answer

Several scenarios make "yes, with caveats" more accurate than a flat yes.

A fragility fracture already sustained — a wrist fracture from a standing-height fall, a vertebral compression — reclassifies you from osteopenia to clinical osteoporosis risk regardless of T-score. Prior fragility fracture is one of the strongest predictors of the next one, and it changes both the surgical plan and the medical plan.

Chronic glucocorticoid use lowers bone quality faster than DXA captures. Steroid-induced bone loss can produce a T-score that looks only mildly low while trabecular architecture is already compromised. Surgeons may treat these patients more conservatively on fixation.

Very elderly patients with osteopenia and dementia or fall risk raise a different question: the periprosthetic fracture risk of uncemented fixation versus the dislocation and medical risk of a longer cemented case. There is no universal answer; the trade-off is individualized.

Patients on or starting osteoporosis drugs need timing coordination. Antiresorptives such as bisphosphonates and denosumab do not prevent hip replacement, but some evidence suggests avoiding starting a potent antiresorptive in the immediate weeks around surgery in certain contexts, while continuing established therapy is generally favored. Anabolic agents like teriparatide or romosozumab are sometimes used before elective arthroplasty in severe osteoporosis to build bone stock, though this is specialist territory. If you are on denosumab, do not stop it abruptly — rebound bone loss is real.

A periprosthetic fracture around an existing implant is a distinct problem. Osteopenia raises that risk, and treatment often involves revision fixation with plates, cerclage, or long stems rather than a primary replacement.

Misconceptions Worth Correcting

The most persistent misconception is that osteopenia forbids hip replacement. It does not. Surgeons operate on osteopenic hips routinely, and outcomes in the osteopenic range are generally good when fixation is matched to bone quality.

A second misconception is that a T-score of −1.5 and −2.4 carry the same surgical weight because both say "osteopenia." They do not. The fracture-risk gradient across that band is steep, and many surgeons escalate their fixation caution as the value approaches −2.5.

A third is that uncemented implants are always modern and therefore always better. In soft bone, cement can be the safer, more durable choice, particularly for the femoral stem.

The counterintuitive detail: cementless fixation can be riskier than cemented fixation specifically in osteopenic and osteoporotic femora, because press-fit impaction can split a brittle proximal femur. The "advanced" implant is not automatically the right implant.

A fourth misconception is that bone density drugs must be finished before surgery. Most patients continue established therapy through the perioperative period; the coordination question is about starting or stopping, not about some blanket rule.

Practical Steps Before and Around Surgery

Get a DXA scan if you have not had one in the last two years, and bring the T-score and FRAX output to your surgical consultation. Ask specifically whether your femoral cortical thickness has been assessed on the preoperative radiograph. Correct vitamin D to at least 30 ng/mL if low, and confirm calcium intake meets age-appropriate targets. These are cheap, low-risk steps that support bone healing. Ask your surgeon which fixation they plan and why — cement versus press-fit, stem geometry, cup fixation. A surgeon who explains the choice in terms of your bone quality is reading your scan, not your age alone. If your T-score is −2.5 or lower, or FRAX crosses the treatment threshold, get a bone-health evaluation before elective surgery. Treatment may start before or after the operation depending on the drug and your fracture risk. If you take denosumab, tell your surgeon and your bone specialist. Do not stop it on your own; timing requires coordination.

Red flags to raise immediately:

A new fracture from a standing-height fall before surgery — this may reclassify your risk and change timing. Unexplained thigh or groin pain if you are on long-term bisphosphonates — this can signal atypical femoral fracture risk and warrants imaging before elective hip surgery. Sudden inability to bear weight after surgery, or a pop with pain — possible periprosthetic fracture; seek urgent evaluation. Fever, wound drainage, or increasing pain weeks after surgery — infection concern, not a bone-density issue, but urgent.

Limitations and What the Evidence Does Not Settle

The evidence base has real gaps. There is no randomized trial that assigns osteopenic patients to cemented versus uncemented fixation by T-score, so the choice rests on registry data, cohort studies, and surgeon experience. T-score itself is an imperfect proxy for bone strength; it measures areal density on a two-dimensional scan, not three-dimensional trabecular architecture or cortical quality. Some osteopenic patients have bone that behaves better than the number suggests, and some with better numbers have fragile bone from steroids or prior fractures.

Fall risk, frailty, and medical comorbidity often matter more to the outcome than the density value alone. A person with osteopenia who falls frequently faces more periprosthetic fracture and dislocation risk than a person with the same T-score who does not fall. The practical answer to the headline question is yes — but the good version of that answer includes a bone-health plan, an implant choice matched to your bone, and an honest conversation about fixation trade-offs rather than a single threshold number.